跳至主要内容
临床试验/TCTR20180913002
TCTR20180913002招募中2 期

Comparison of inhaled nebulized nitrite and oral sildenafil VS oral sildenafil alonein the treatment of beta-thalassemia patients with pulmonary hypertension

Department of Pharmacology at Faculty of Science, Mahidol University0 个研究点目标入组 50 人开始时间: 2018年9月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Age ≥ 18 years old
  • Beta-thalassemia patients diagnosed with pulmonary hypertension type 5 (WHO criteria)
  • Right heart catheterization ; MPAP ≥ 25 mmHg and PCWP < 15 mmHg
  • TR Vmax ≥  2.8 m/s or RVSP ≥ 35 mmHg will undergo to right heart catherization

排除标准

  • -Currently use organic nitrate
  • -Currently treated with other PAH -specific drugs (except sildenafil)
  • -Hb < 7 mg/dL
  • -Plasma methemoglobin level > 4%
  • -Symptomatic left sided heart failure
  • -History ischemic heart disease
  • -Uncontrolled DM
  • -Uncontrolled thyroid disorder
  • -Cirrhosis
  • -Pregnancy
  • -No inform consent

研究者

发起方
Department of Pharmacology at Faculty of Science&#44; Mahidol University

相似试验